Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.17 (
PCE
)
1,301
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Under the Superfund Innovative Technology Evaluation (SITE) Program, a technology developed by
AWD
Technologies, Inc. was demonstrated in September 1990. This paper presents the major results of the SITE demonstration of
AWD
Technologies' AquaDetox/SVE treatment system designed for simultaneous on-site treatment of contaminated groundwater and soil-gas. The groundwater and soil at the demonstration site were contaminated with trichloroethylene (TCE) and tetrachloroethylene (
PCE
). The
AWD
technology was evaluated on the basis of the removal efficiencies of TCE and
PCE
from the contaminated groundwater and soil-gas. The conclusions drawn from these evaluations are: (1) the system achieved removal efficiencies as high as 99.99 percent for groundwater and 99.9 percent for soil-gas; (2) the effluent groundwater was in compliance with the regulatory discharge requirements of 5 micrograms/L each for TCE and
PCE
for all test runs; (3) the demonstrated 1,000 gpm system has an estimated capital cost of $4.3 million and annual operating and maintenance cost of approximately $820,000.
...
PMID:U.S. EPA SITE demonstration of AWD Technologies' AquaDetox/SVE system. 178 57